Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNavitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo.AuthorsAckler, S; Mitten, MJ; Chen, J; Clarin, J; Foster, K; Jin, S; Phillips, DC; Schlessinger, S; Wang, B; Leverson, JD; Boghaert, ERPublicationBritish Journal of Pharmacology, 2012, Vol 167, Issue 4, p881ISSN0007-1188Publication typeArticleDOI10.1111/j.1476-5381.2012.02048.x